Search results

Results 1 to 10 of 74 for "Chemoresistance"

• ( 3 )
• Best Basic Science Research Paper ( 1 )
• Best Clinical Research Paper ( 1 )
• Bone and Soft Tissue Sarcomas ( 3 )
• Breast Oncology ( 4 )
• Editorial ( 2 )
• Editorials ( 1 )
• Education Review ( 1 )
• Educational Review ( 1 )
• Endocrine Tumors ( 1 )
• Gastrointestinal Oncology ( 8 )
• Gynecologic Oncology ( 1 )
• Head and Neck Oncology ( 1 )
• Healthcare Policy and Outcomes ( 2 )
• Hepatic and Pancreatic Tumors ( 2 )
• Hepatobiliary Tumors ( 1 )
• Lab Research ( 1 )
• Laboratory Research ( 2 )
• Medical Oncology ( 1 )
• Melanomas ( 1 )
• Neuro-Oncology ( 2 )
• New Approaches to the Treatment of Hepatic Malignancies ( 1 )
• Original Article ( 1 )
• Original Articles ( 2 )
• Regional Cancer Therapies ( 1 )
• Thoracic Oncology ( 3 )
• Translational Research and Biomarkers ( 26 )

• In the last month ( 1 )
• In the last six months ( 4 )
• In the last year ( 9 )

1. In Vitro Chemoresistance Testing in Well-Differentiated Carcinoid Tumors

   John M. Lyons III MD, Jeffrey Abergel MD, Jessica L. Thomson PhD, Cathy T. Anthony PhD, Yi-Zarn Wang MD, DDS, Lowell B. Anthony MD, J. Philip Boudreaux MD, James Strauchen MD, Muhammad Idrees MD, Richard R. P. Warner MD, Eugene A. Woltering MD

   Volume 16, Number 3 / March, 2009

   Endocrine Tumors

   View abstract | View full article on SpringerLink | View full article PDF

2. Flow cytometric measurement of mitochondrial mass and function: A novel method for assessing chemoresistance

   Mariangela Mancini MD, Monireh Sedghinasab MS, Katya Knowlton MD, Amy Tam MS, David Hockenberg MD, Benjamin O. Anderson MD

   Volume 5, Number 3 / April, 1998

   Best Basic Science Research Paper

   View abstract | View full article on SpringerLink | View full article PDF

3. Overexpression of Forkhead Box M1 Transcription Factor (FOXM1) is a Potential Prognostic Marker and Enhances Chemoresistance for Docetaxel in Gastric Cancer

   Kaoru Okada MD, Yoshiyuki Fujiwara MD, PhD, Tsuyoshi Takahashi MD, PhD, Yurika Nakamura PhD, Shuji Takiguchi MD, PhD, Kiyokazu Nakajima MD, PhD, Hiroshi Miyata MD, PhD, Makoto Yamasaki MD, PhD, Yukinori Kurokawa MD, PhD, Masaki Mori MD, PhD, Yuichiro Doki MD, PhD

   Volume 20, Number 3 / March, 2013

   Gastrointestinal Oncology

   View abstract | View full article on SpringerLink | View full article PDF

4. Evaluation of ERCC1 Expression for Cisplatin Sensitivity in Human Hepatocellular Carcinoma

   Shigeru Ueda MD, Ken Shirabe MD, Kazutoyo Morita MD, Kenji Umeda MD, Hiroto Kayashima MD, Hideaki Uchiyama MD, Yuji Soejima MD, Akinobu Taketomi MD, Yoshihiko Maehara MD

   Volume 18, Number 4 / April, 2011

   Translational Research and Biomarkers

   View abstract | View full article on SpringerLink | View full article PDF

5. Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells

   Ami N. Shah, Justin M. Summy, Jing Zhang, Serk In Park, Nila U. Parikh, Gary E. Gallick

   Volume 14, Number 12 / December, 2007

   Laboratory Research

   View abstract | View full article on SpringerLink | View full article PDF

6. MicroRNA-10b is a Prognostic Indicator in Colorectal Cancer and Confers Resistance to the Chemotherapeutic Agent 5-Fluorouracil in Colorectal Cancer Cells

   Naohiro Nishida MD, Shinya Yamashita MD, Koshi Mimori MD, PhD, Tomoya Sudo MD, PhD, Fumiaki Tanaka MD, PhD, Kohei Shibata MD, PhD, Hirofumi Yamamoto MD, PhD, Hideshi Ishii MD, PhD, Yuichiro Doki MD, PhD, Masaki Mori MD, PhD, FACS

   Volume 19, Number 9 / September, 2012

   Translational Research and Biomarkers

   View abstract | View full article on SpringerLink | View full article PDF

7. Overcoming Antiapoptotic Responses to Promote Chemosensitivity in Metastatic Colorectal Cancer to the Liver

   James C. Cusack Jr. MD

   Volume 10, Number 8 / September, 2003

   New Approaches to the Treatment of Hepatic Malignancies

   View abstract | View full article on SpringerLink | View full article PDF

8. Inhibition of Proliferation by Omega-3 Fatty Acids in Chemoresistant Pancreatic Cancer Cells

   Justin Hering MD, Sean Garrean MD, Thomas R. Dekoj MD, Anthony Razzak BS, Abdul Saied MD, Jose Trevino MD, Tricia A. Babcock MS, N. Joseph Espat MD, MS, FACS

   Volume 14, Number 12 / December, 2007

   Hepatic and Pancreatic Tumors

   View abstract | View full article on SpringerLink | View full article PDF

9. Allelic Imbalance at p53 and Microsatellite Instability Are Predictive Markers for Resistance to Chemotherapy in Gastric Carcinoma

   Masakazu Yashiro MD, PhD, Toru Inoue MD, PhD, Nobuaki Nishioka MD, PhD, Tasuku Matsuoka MD, PhD, C. Richard Boland MD, PhD, Kosei Hirakawa MD, PhD

   Volume 16, Number 10 / October, 2009

   Translational Research and Biomarkers

   View abstract | View full article on SpringerLink | View full article PDF

10. Expression Analysis of Aldehyde Dehydrogenase 1A1 (ALDH1A1) in Colon and Rectal Cancer in Association with Prognosis and Response to Chemotherapy

    Christoph Kahlert MD, Eva Gaitzsch BA (hons), Gunnar Steinert PhD, Carolin Mogler MD, Esther Herpel MD, Michael Hoffmeister PhD, MSc, Lina Jansen PhD, MSc, Axel Benner MSc, Hermann Brenner MD, MPH, Jenny Chang-Claude PhD, MHS, Nuh Rahbari MD, Thomas Schmidt MD, Fee Klupp MD, Niels Grabe MD, Bernd Lahrmann MSc, Moritz Koch MD, Niels Halama MD, Markus Büchler MD, Juergen Weitz MD, MSc

    Volume 19, Number 13 / December, 2012

    Healthcare Policy and Outcomes

    View abstract | View full article on SpringerLink | View full article PDF

• 1
• 2
• 3
• 4
• 5
• >
• >>